FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081151946> ?p ?o ?g. }

• W2081151946 endingPage "1269" @default.
• W2081151946 startingPage "1264" @default.
• W2081151946 abstract "Background. Patients whose Hodgkin's disease is refractory to standard combination chemotherapy usually have a poor prognosis. These patients are generally considered for bone marrow transplantation if the disease is still sensitive to chemotherapy. Methods. Between May 1988 and January 1992, 19 patients with refractory or relapsed Hodgkin's disease were treated with a regimen of doxorubicin, bleomycin, dacarbazine, lomustine, and prednisone (ABDIC). The ABDIC regimen as modified for continuous infusion by Hagemeister consisted of doxorubicin 25 mg/m2 by continuous infusion daily for 2 days, dacarbazine 200 mg/m2 by continuous infusion daily for 5 days, bleomycin 5 U/m2 intravenously on days 1 and 5, CCNU 40 mg/m2 on day l, and prednisone 40 mg/m2 daily on days 1–5. Treatment was repeated every 28 days. Results. At the time of treatment, mean age was 30.5 years (range 19–70), and time to ABDIC from initial diagnosis was 5.6 years (range 1–14). The mean number of prior chemotherapy regimens was 2.7 (range 1–5), and three of the patients had had autologous bone marrow transplantation before ABDIC. All patients had earlier received either mechlorethamine, vincristine, procarbazine, and prednisone or a regimen of doxorubicin, bleomycin, vinblastine, and dacarbazine, and 16 had received both. The mean number of ABDIC cycles was 3.9 (range 2–12). Total response rate was 63%, with 10 patients having partial response and 2 having complete response of 12 and 27 months' duration. Seven patients subsequently underwent bone marrow transplantation; two of these are free of disease at 35 and 41 months. The treatment was well tolerated; major toxicities were nausea and bone marrow suppression. Conclusion. ABDIC is an active and well tolerated therapy in patients with relapsed or refractory Hodgkin's disease, including those previously treated with ABVD. More importantly, perhaps, ABDIC as cytoreductive therapy followed by bone marrow transplantation offers the possibility of long term disease free survival in this heavily pretreated patient population." @default.
• W2081151946 created "2016-06-24" @default.
• W2081151946 creator A5011932835 @default.
• W2081151946 creator A5014149835 @default.
• W2081151946 creator A5018568317 @default.
• W2081151946 creator A5026196917 @default.
• W2081151946 creator A5033267787 @default.
• W2081151946 creator A5048763865 @default.
• W2081151946 creator A5089854184 @default.
• W2081151946 date "1994-02-15" @default.
• W2081151946 modified "2023-10-17" @default.
• W2081151946 title "Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease" @default.
• W2081151946 cites W1856398768 @default.
• W2081151946 cites W1887945714 @default.
• W2081151946 cites W1888835857 @default.
• W2081151946 cites W1953363065 @default.
• W2081151946 cites W1956649414 @default.
• W2081151946 cites W1972264308 @default.
• W2081151946 cites W1977602877 @default.
• W2081151946 cites W1983722005 @default.
• W2081151946 cites W2014698797 @default.
• W2081151946 cites W2041629407 @default.
• W2081151946 cites W2055310422 @default.
• W2081151946 cites W2075898541 @default.
• W2081151946 cites W2086855064 @default.
• W2081151946 cites W2090073172 @default.
• W2081151946 cites W2156906636 @default.
• W2081151946 cites W2185768010 @default.
• W2081151946 cites W2258178785 @default.
• W2081151946 cites W2269861991 @default.
• W2081151946 cites W2273350722 @default.
• W2081151946 cites W2288629080 @default.
• W2081151946 cites W2494592270 @default.
• W2081151946 doi "https://doi.org/10.1002/1097-0142(19940215)73:4<1264::aid-cncr2820730422>3.0.co;2-q" @default.
• W2081151946 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7508818" @default.
• W2081151946 hasPublicationYear "1994" @default.
• W2081151946 type Work @default.
• W2081151946 sameAs 2081151946 @default.
• W2081151946 citedByCount "7" @default.
• W2081151946 crossrefType "journal-article" @default.
• W2081151946 hasAuthorship W2081151946A5011932835 @default.
• W2081151946 hasAuthorship W2081151946A5014149835 @default.
• W2081151946 hasAuthorship W2081151946A5018568317 @default.
• W2081151946 hasAuthorship W2081151946A5026196917 @default.
• W2081151946 hasAuthorship W2081151946A5033267787 @default.
• W2081151946 hasAuthorship W2081151946A5048763865 @default.
• W2081151946 hasAuthorship W2081151946A5089854184 @default.
• W2081151946 hasBestOaLocation W20811519461 @default.
• W2081151946 hasConcept C126322002 @default.
• W2081151946 hasConcept C141071460 @default.
• W2081151946 hasConcept C2776305933 @default.
• W2081151946 hasConcept C2776694085 @default.
• W2081151946 hasConcept C2776755627 @default.
• W2081151946 hasConcept C2777132456 @default.
• W2081151946 hasConcept C2778336483 @default.
• W2081151946 hasConcept C2778720950 @default.
• W2081151946 hasConcept C2779112685 @default.
• W2081151946 hasConcept C2779429289 @default.
• W2081151946 hasConcept C2779434656 @default.
• W2081151946 hasConcept C2780964509 @default.
• W2081151946 hasConcept C2781413609 @default.
• W2081151946 hasConcept C2911091166 @default.
• W2081151946 hasConcept C71924100 @default.
• W2081151946 hasConcept C90924648 @default.
• W2081151946 hasConceptScore W2081151946C126322002 @default.
• W2081151946 hasConceptScore W2081151946C141071460 @default.
• W2081151946 hasConceptScore W2081151946C2776305933 @default.
• W2081151946 hasConceptScore W2081151946C2776694085 @default.
• W2081151946 hasConceptScore W2081151946C2776755627 @default.
• W2081151946 hasConceptScore W2081151946C2777132456 @default.
• W2081151946 hasConceptScore W2081151946C2778336483 @default.
• W2081151946 hasConceptScore W2081151946C2778720950 @default.
• W2081151946 hasConceptScore W2081151946C2779112685 @default.
• W2081151946 hasConceptScore W2081151946C2779429289 @default.
• W2081151946 hasConceptScore W2081151946C2779434656 @default.
• W2081151946 hasConceptScore W2081151946C2780964509 @default.
• W2081151946 hasConceptScore W2081151946C2781413609 @default.
• W2081151946 hasConceptScore W2081151946C2911091166 @default.
• W2081151946 hasConceptScore W2081151946C71924100 @default.
• W2081151946 hasConceptScore W2081151946C90924648 @default.
• W2081151946 hasIssue "4" @default.
• W2081151946 hasLocation W20811519461 @default.
• W2081151946 hasLocation W20811519462 @default.
• W2081151946 hasOpenAccess W2081151946 @default.
• W2081151946 hasPrimaryLocation W20811519461 @default.
• W2081151946 hasRelatedWork W141689507 @default.
• W2081151946 hasRelatedWork W2019922408 @default.
• W2081151946 hasRelatedWork W2075898541 @default.
• W2081151946 hasRelatedWork W2077424156 @default.
• W2081151946 hasRelatedWork W2078961499 @default.
• W2081151946 hasRelatedWork W2081151946 @default.
• W2081151946 hasRelatedWork W2103525635 @default.
• W2081151946 hasRelatedWork W2338320264 @default.
• W2081151946 hasRelatedWork W2394876087 @default.
• W2081151946 hasRelatedWork W2465733539 @default.
• W2081151946 hasVolume "73" @default.
• W2081151946 isParatext "false" @default.
• W2081151946 isRetracted "false" @default.

• next